{"id":18153,"date":"2024-08-30T10:00:19","date_gmt":"2024-08-30T08:00:19","guid":{"rendered":"https:\/\/world-heart-federation.org\/?post_type=news&p=18153"},"modified":"2024-08-30T13:18:46","modified_gmt":"2024-08-30T11:18:46","slug":"a-quarter-of-patients-in-whf-study-still-experiencing-persistent-long-covid-symptom-after-one-year","status":"publish","type":"news","link":"https:\/\/world-heart-federation.org\/news\/a-quarter-of-patients-in-whf-study-still-experiencing-persistent-long-covid-symptom-after-one-year\/","title":{"rendered":"A quarter of patients in WHF Study still experiencing persistent long COVID symptom after one year"},"content":{"rendered":"

Following the success of the Global Study on Cardiovascular Disease (CVD) and COVID-19, and to better understand long COVID<\/span>, especially in low-resource settings, World Heart Federation (WHF) commenced the WHF Long COVID Sub-study in early 2022. This sub-study aimed to determine the short-term (3 months), medium-term (6 months), and long-term (12 months) sequelae of COVID-19, including re-hospitalization and mortality, symptoms, impact on physical function, and psycho-social consequences. Twenty-six hospitals from 16 countries (Bangladesh, Brazil, Colombia, India, Indonesia, Iran, Japan, Kenya, Malaysia, Mexico, Nigeria, Pakistan, Portugal, Russia, South Africa, Zambia) recruited 2,535 hospitalized COVID-19 patients from January 2022 to August 2023. Subsequently, these patients were contacted via telephone for follow-up assessments at four different time points: 1-month, 3-months, 6-months, and 9-12-month after hospital discharge. Follow ups for all eligible patients were completed in January 2024, with a follow-up rate of 90%.<\/p>\n